**Author Information** An event is serious (based on the ICH definition) when the patient outcome is:\* death\* life-threatening\* hospitalisation\* disability\* congenital anomaly\* other medically important event

A 72-year-old man developed acute haemolytic anaemia following off-label treatment with hydroxychloroquine for coronavirus disease 2019 (COVID-19).

The man was admitted to a hospital in Italy with dyspnoea, fatigue, dizziness and fever. He had developed ischaemic cardiomyopathy and had recently undergone stent placement in the interventricular coronary artery. On further evaluation, a significant reduction in oxygen saturation level and the bilateral interstitial pneumonia were detected and hence, he was diagnosed with COVID-19. He was then shifted to the COVID-19 unit and off-label treatment with lopinavir/ritonavir \[lopinavir\] [1](#Fn1){ref-type="fn"} and hydroxychloroquine \[hydroxychloroquine sulfate; *dosage and route not stated*\] along with provisional oxygen support were initiated. After 48 hours of admission, an acute drop in haemoglobin level secondary to the appearance of haemoglobinuria was noted. His C-reactive protein value was elevated. Both indirect and direct antiglobulin tests were negative, however an immune-mediated acute haemolysis was observed. The peripheral blood smears showed reticulocytes characterised by large and round-shaped cells, anisopoikilocytosis, microspherocytes, some hemighost cells were characterised by packed haemoglobin from one side and large vacuum cytoplasm and schistocytes (2-3%), which were suggestive of a blistering process. A final diagnosis of acute haemolytic anaemia secondary to hydroxychloroquine was made \[*duration of treatment to reaction onset and outcome not stated*\]. The role of suspected glucose-6-phosphate-dehydrogenase (G6PD) deficiency in COVID-19 lung disease was also considered as culprit. His therapy with hydroxychloroquine was discontinued and he was transfused.

Lopinavir is always available in fixed drug combination with Ritonavir.
